BRIEF-Kailos genetics enters into a co-marketing agreement with Illumina
March 21, 2017 at 09:11 AM EDT
* Illumina will market and promote Kailos Targetrich line of research solutions for pharmacogenetics targets through commercial channels Source text for Eikon: Further company coverage:
